Harrow Inc (NASDAQ:HROW) reported a 45% increase in total revenue for the third quarter compared to the same period in 2024, ...
Get key insights from Harrow’s Q3 2025 earnings: strong growth in ophthalmic meds, major VEVYE coverage wins, and updated financial outlook.
In our strange new AI reality, I put the top AI video generators to the test to find the ultimate winner. Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback